Testing siponimod for mild Alzheimer's dementia
Part of Brain & nervous system, Mental health clinical trials.
This study tests if a medicine called siponimod, already used for multiple sclerosis, can help people with mild Alzheimer's dementia. You will take a pill daily and be monitored closely for safety and cognitive changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 84 years old.
- You have a diagnosis of mild Alzheimer's dementia.
- You need a family member or friend who can help with study visits and medications.
- You must be able to take pills by mouth and attend all study visits.
- You cannot have certain heart, immune, or other serious health issues.
- You must have had a recent brain scan (CT or MRI) showing no other cause for memory problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests an oral medicine (EX039) to see if it can help people with mild Alzheimer’s disease. It focuses on slowing or improving thinking and memory problems over time.
This study tests a new drug called NSC001 for people with mild to moderate Alzheimer's. It checks if the drug is safe and if it might help slow memory decline. You'll need a caregiver who can join you at visits and help track your progress.
This Phase 2 study tests whether sargramostim (a GM-CSF related medicine) is safe and can slow or improve Alzheimer’s symptoms. You might be a good fit if you have mild or moderate Alzheimer’s, positive amyloid testing, and can complete frequent visits with a close caregiver who knows you well.
This trial tests an oral drug called lenalidomide (often used for immune conditions) to see if it can help people with early memory loss due to Alzheimer's. You would need a study partner, be willing to have spinal taps and brain scans, and have a positive amyloid PET scan.
This trial tests whether a daily pill called ozanimod can help people with moderate Alzheimer's disease. The study monitors changes in thinking and memory over time and requires a study partner who can join visits.
This study tests a new medicine, NVP-NK4146, for people with mild cognitive impairment (MCI) due to Alzheimer's disease. The goal is to see if it can help slow down memory and thinking problems.
Hear when a new Mild Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.